Anthony Petrone
Stock Analyst at Mizuho
(3.72)
# 686
Out of 5,182 analysts
218
Total ratings
49.7%
Success rate
7.67%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNKD MannKind | Maintains: Outperform | $10 → $8 | $2.63 | +204.18% | 1 | Apr 13, 2026 | |
| MDT Medtronic | Maintains: Outperform | $125 → $120 | $82.92 | +44.72% | 8 | Apr 13, 2026 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $85 → $95 | $84.11 | +12.95% | 9 | Apr 13, 2026 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $575 → $525 | $470.99 | +11.47% | 7 | Apr 13, 2026 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $85 → $70 | $55.07 | +27.11% | 9 | Apr 13, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $80 → $70 | $60.48 | +15.74% | 18 | Apr 13, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $90 | $70.48 | +27.70% | 7 | Apr 13, 2026 | |
| EW Edwards Lifesciences | Maintains: Outperform | $100 → $95 | $83.46 | +13.83% | 11 | Apr 13, 2026 | |
| EMBC Embecta | Maintains: Neutral | $14 → $12 | $9.21 | +30.29% | 4 | Apr 13, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $90 | $59.95 | +50.13% | 10 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $24 | $10.93 | +119.58% | 7 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $21 | $12.92 | +62.54% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $100 | $65.47 | +52.74% | 10 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $22 | $19.82 | +11.00% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $90 | $61.41 | +46.56% | 4 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $3.34 | +199.40% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $72 | $63.41 | +13.55% | 10 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $120 | $88.50 | +35.59% | 4 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $100 | $64.34 | +55.42% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $39.39 | +1.55% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $100 | $76.01 | +31.56% | 11 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $300 | $222.02 | +35.12% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $135.07 | -0.05% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $92.80 | +45.47% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $26.68 | -32.53% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $122.07 | +43.36% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $7.27 | +450.21% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $60.93 | -4.81% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $114.52 | -41.49% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $92.59 | +89.01% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $12.71 | +96.70% | 3 | May 13, 2020 |
MannKind
Apr 13, 2026
Maintains: Outperform
Price Target: $10 → $8
Current: $2.63
Upside: +204.18%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125 → $120
Current: $82.92
Upside: +44.72%
Lantheus Holdings
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $95
Current: $84.11
Upside: +12.95%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575 → $525
Current: $470.99
Upside: +11.47%
Inspire Medical Systems
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $70
Current: $55.07
Upside: +27.11%
Haemonetics
Apr 13, 2026
Maintains: Outperform
Price Target: $80 → $70
Current: $60.48
Upside: +15.74%
GE HealthCare Technologies
Apr 13, 2026
Maintains: Outperform
Price Target: $95 → $90
Current: $70.48
Upside: +27.70%
Edwards Lifesciences
Apr 13, 2026
Maintains: Outperform
Price Target: $100 → $95
Current: $83.46
Upside: +13.83%
Embecta
Apr 13, 2026
Maintains: Neutral
Price Target: $14 → $12
Current: $9.21
Upside: +30.29%
Boston Scientific
Apr 13, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $59.95
Upside: +50.13%
Apr 13, 2026
Maintains: Outperform
Price Target: $30 → $24
Current: $10.93
Upside: +119.58%
Mar 31, 2026
Initiates: Outperform
Price Target: $21
Current: $12.92
Upside: +62.54%
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $65.47
Upside: +52.74%
Feb 20, 2026
Maintains: Neutral
Price Target: $21 → $22
Current: $19.82
Upside: +11.00%
Feb 13, 2026
Maintains: Outperform
Price Target: $78 → $90
Current: $61.41
Upside: +46.56%
Dec 17, 2025
Maintains: Outperform
Price Target: $12 → $10
Current: $3.34
Upside: +199.40%
Dec 17, 2025
Maintains: Outperform
Price Target: $70 → $72
Current: $63.41
Upside: +13.55%
Dec 17, 2025
Maintains: Outperform
Price Target: $100 → $120
Current: $88.50
Upside: +35.59%
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $64.34
Upside: +55.42%
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $39.39
Upside: +1.55%
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $76.01
Upside: +31.56%
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $222.02
Upside: +35.12%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $135.07
Upside: -0.05%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $92.80
Upside: +45.47%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $26.68
Upside: -32.53%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $122.07
Upside: +43.36%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $7.27
Upside: +450.21%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $60.93
Upside: -4.81%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $114.52
Upside: -41.49%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $92.59
Upside: +89.01%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $12.71
Upside: +96.70%